Search company, investor...

Compare Longevica vs Neurobiological Technologies

Customers evaluate the quality of Longevica's products using the following success metrics.

Overview

Longevica Logo

Longevica is based in United States

Longevica is a biotechnology that is researching mechanisms of healthy aging and life extension. The company is also developing an open research tool for scientists and research institutions to access a data set that tracks the effects of pharmacological compounds for testing drugs.

Neurobiological Technologies is 37 yrs old and is based in United States.

Neurobiological Technologies, Inc. (NTI) (Nasdaq: NTII) is an emerging drug development company focused on the clinical development and regulatory approval of neuroscience drugs. The company is involved and develops neuroprotective and neuromodulatory agents to treat progressive neurological impairments characteristic of various nervous system disorders, including Alzheimer's Disease, diabetic neuropathy and brain cancer. The company's scientific focus is neuroprotection, or the prevention or amelioration of neuronal injury associated with a variety of acute, chronic and degenerative neurological conditions. Damaged neurons contribute significantly to functional impairment in many peripheral and central nervous system disorders, including chronic diseases such as diabetes, AIDS, and Alzheimer's disease. NTI is developing potential neuroprotective drugs to inhibit important pathways that lead to nerve cell damage, including calcium influx caused by glutamate leak (excitotoxicity) and cerebral edema (swelling of the brain).

Country

United States

Demo Video

Longevica did not submit their demo in their Analyst Briefing

Work for Longevica?

Demo not available because Neurobiological Technologies has not claimed their profile.

Work for Neurobiological Technologies? Show off your product.

Leadership

Ainar Abdrakhmanov (Founder, Chief Executive Officer)

See all 4 people

Funding

Longevica last raised $2.5M on 11/24/2021.

Investors

Xploration Capital, Foundation Venture Capital Group

See all 3 investors

Iroquois Capital Group, Highbridge Capital Management

See all 5 investors

Product

Why Longevica beats Neurobiological Technologies

    Information not available because Neurobiological Technologies has not claimed their profile.

    Work for Neurobiological Technologies? Claim your profile by submitting an Analyst Briefing. By submitting you can

    Show your primary competitive advantage
    Highlight your competitive differentiation
    Show why customers evalute your products
    Explain why customers choose your products and services

    Work for Neurobiological Technologies?

    Claim your profile now.

    Benefits

    • Annual Revenue Improvement
    • Patient Income Per Provider
    • Lower Hospital Readmissions

    Products

    • Health Base

      The Longevica Health Base is a home health monitoring center that supports you to better adhere to chronic medication treatments and gain easier access to digital health tools to promote healthy aging and daily betterment of living. Caregivers will also gain a peace of mind that their loved ones are improving lifestyle wellness and in stable health.

    See all products

    Customers

    Longevica did not submit their products in their Analyst Briefing

    Work for Longevica?

    Known Partners

    Longevica did not submit their partners in their Analyst Briefing

    Work for Longevica?

    Why They Buy

    Longevica did not submit their references in their Analyst Briefing

    Work for Longevica?